WALTHAM, Mass., March 28, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and Chief Scientific Officer, will present at the 20th Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel and Conference Center in New York City on Friday, April 5, 2013 at 1:30 p.m. EDT.
Interested parties may access a live audio webcast of the presentation via the investors section of the TESARO website, www.tesarobio.com. A replay of the webcast will be archived on the TESARO website for 14 days.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
The TESARO, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13456
CONTACT: For further information contact: Jennifer Davis Senior Director, Corporate Development and Investor Relations +1.781.325.1116 email@example.com